Search

everythinglearnresearchcommunity

for

Search:↓

IVIG therapy was linked to hair regrowth in two patients with hair loss, but it's not recommended due to its risks and costs.

The study concluded that tick infestation was the most common skin problem in hospitalized dogs in Chennai, with various treatments used for different conditions.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

The document concludes that understanding hair biology is key to treating hair disorders, with gene therapy showing potential as a future treatment.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

Hair growth phase and certain genes can speed up wound healing, while an inflammatory mediator can slow down new hair growth after a wound. Understanding these factors can improve tissue regeneration during wound healing.

The document concludes that mouse models are helpful but have limitations for skin wound healing research, and suggests using larger animals and genetically modified mice for better human application.

Biomaterials with MSC-derived substances could improve tissue repair and have advantages over direct cell therapy.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Stress increases a factor in mice that leads to hair loss, and blocking this factor may prevent it.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Advanced human skin models improve drug development and could replace animal testing.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Hydrogels could lead to better treatments for wound healing without scars.

Stress may trigger hair loss by affecting immune protection in hair follicles.

Fat cells are important for tissue repair and stem cell support in various body parts.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Hair loss in Rhesus macaques may be caused by a skin allergy-related condition.

The new nanocomposite films are stronger, protect against UV, speed up wound healing, and are antibacterial without being toxic.

Birth control pills can help manage acne, but dermatologists should know their skin-related side effects, especially when prescribing drugs that can harm unborn babies.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

The spiny mouse can regenerate its skin without scarring, which could help us learn how to heal human skin better.

EGFR inhibitors can cause yellowish skin eruptions.

Dengue virus can infect human hair follicle cells and may cause hair loss.

Newborns with the common rash Erythema Toxicum have many active mast cells in their skin, but these cells don't produce the LL-37 peptide.

Follicular Cell Implantation might become a new treatment for hair loss and could lead to advances in organ regeneration.

Four specific genes are linked to keloid formation and could be potential treatment targets.

Proteoglycans are important for hair growth, and a specific treatment can help reduce hair loss.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.